Perfil
Itzhak D.
Goldberg is the founder of Angion Biomedica Corp.
which was founded in 1998.
He held the titles of Executive Chairman & Chief Scientific Officer from 2018 to 2022.
Dr. Goldberg's former job was as a Professor-Radiation Oncology at Albert Einstein College of Medicine, Inc. Dr. Goldberg received his doctorate degree from Albert Einstein College of Medicine, Inc. in 1976.
Antiguos cargos conocidos de Itzhak D. Goldberg.
| Empresas | Cargo | Fin |
|---|---|---|
| Albert Einstein College of Medicine, Inc. | Corporate Officer/Principal | - |
| ANGN BIOM | Chief Executive Officer | 01/03/2018 |
Formación de Itzhak D. Goldberg.
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Itzhak D. Goldberg
